A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy, Immunogenicity, and Safety of Two Single Doses of RRV TV in Neonates/Infants.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy, Immunogenicity, and Safety of Two Single Doses of RRV TV in Neonates/Infants.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs Rhesus rotavirus vaccine reassortant (Primary)
  • Indications Diarrhoea; Gastroenteritis; Rotavirus infections
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 18 Jun 2013 Results have been published in the Journal of Infectious Diseases, according to a media release from The International Medica Foundation.
    • 23 Nov 2011 New source identified and integrated (Pan-African Clinical Trials Registry).
    • 23 Nov 2011 Official title amended, actual initiation date 28 Aug 2009 and company added in the association field, additional trial location (South Africa) identified as reported by Pan-African Clinical Trials Registry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top